verapamil has been researched along with chlorthalidone in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (29.63) | 18.7374 |
1990's | 10 (37.04) | 18.2507 |
2000's | 5 (18.52) | 29.6817 |
2010's | 4 (14.81) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Albanesi, FM; Albuquerque, DC; Benchimol, AB; Benchimol, CB; Rocha, PJ; Schlesinger, P | 1 |
Dal Palù, C; Magnani, B; Zanchetti, A | 1 |
Durel, LA; Hayashi, PJ; Schneiderman, N; Weidler, DJ | 1 |
Gerstenblith, G | 1 |
Hergueta García de Guadiana, G; Paumard Fraguas, A | 1 |
Achilli, L; D'Amico, F; Latini, R; Lombi, V; Pierandrei, G | 1 |
Ajzen, H; de Albuquerque, EM; Draibe, SA; Gelman, A; Reynaldo Stella, S | 1 |
Dobbs, RJ; Phillips, RJ; Robinson, BF | 1 |
Candau, LA; Pereira, LS; Scherr, C | 1 |
Barretto, AC; Godoy, M; Pileggi, F; Solorzano, J; Wajngarten, M | 1 |
Chequer, CV; Fernandes, EO; Latreca, CE; Reis, NB; Talberg, J | 1 |
Antonicelli, R; Gambini, C; Paciaroni, E; Sardina, M; Savonitto, S; Tomassini, PF | 1 |
Zanchetti, A | 1 |
Boehlen, L; Buechel, P; Lerch, M; Papiri, M; Risen, W; Schneider, M; Shaw, S; Weidmann, P | 1 |
de Leeuw, PW; Notter, T; Zilles, P | 1 |
Dal Palù, C; Leonetti, G; Magnani, B; Pessina, A; Rosei, EA; Zanchetti, A | 2 |
Gómez Guindal, JA; González Lama, I; González Maqueda, I | 1 |
Beck, K; Holzgreve, H; Janka, HU; Nakov, R | 1 |
Fomin, VV; Moiseev, SV | 1 |
3 review(s) available for verapamil and chlorthalidone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Fixed-dose combination therapy: reduction of side effects with enhanced tolerance and antihypertensive efficacy].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Chlorthalidone; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Drug Tolerance; Humans; Hypertension; Indoles; Patient Compliance; Time Factors; Vasodilator Agents; Verapamil | 1999 |
[Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Carotid Artery Diseases; Carotid Artery, Common; Chlorthalidone; Drug Therapy, Combination; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Ultrasonography; Vasodilator Agents; Verapamil | 2005 |
15 trial(s) available for verapamil and chlorthalidone
Article | Year |
---|---|
Preliminary clinical experience with calcium antagonists in atherosclerosis. Verapamil in Hypertension Atherosclerosis Study Investigators.
Topics: Adult; Aged; Arteriosclerosis; Blood Pressure; Carotid Arteries; Chlorthalidone; Delayed-Action Preparations; Double-Blind Method; Heart Rate; Humans; Hypertension; Middle Aged; Verapamil | 1992 |
Effectiveness of antihypertensive medications in office and ambulatory settings: a placebo-controlled comparison of atenolol, metoprolol, chlorthalidone, verapamil, and an atenolol-chlorthalidone combination.
Topics: Adult; Ambulatory Care; Antihypertensive Agents; Atenolol; Blood Pressure; Blood Pressure Determination; Chlorthalidone; Double-Blind Method; Drug Combinations; Humans; Hypertension; Metoprolol; Middle Aged; Monitoring, Physiologic; Office Visits; Verapamil | 1992 |
Special considerations in the elderly patient.
Topics: Age Factors; Aged; Aging; Atenolol; Blood Pressure; Cardiac Output; Cardiomegaly; Chlorthalidone; Dose-Response Relationship, Drug; Echocardiography; Humans; Hypertension; Middle Aged; Myocardial Contraction; Risk Factors; Verapamil | 1990 |
[Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension].
Topics: Aged; Chlorthalidone; Female; Humans; Hypertension; Male; Middle Aged; Verapamil | 1989 |
[Hypotensive efficacy of verapamil alone and in combination with a diuretic in the treatment of essential hypertension in geriatric patients].
Topics: Aged; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Posture; Verapamil | 1987 |
[Clinical evaluation of the effect of verapamil in hypertensive patients].
Topics: Adult; Aged; Blood Pressure; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Placebos; Reserpine; Verapamil | 1983 |
[Comparative study of the combination of chlorthalidone with verapamil and metoprolol in arterial hypertension: evaluation by cycloergometrics].
Topics: Adult; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Exercise Test; Hemodynamics; Humans; Hypertension; Male; Metoprolol; Middle Aged; Propanolamines; Verapamil | 1981 |
[Treatment of arterial hypertension in patients refractory to therapeutic diuretics. Comparative study of verapamil and propranolol].
Topics: Adult; Chlorthalidone; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Propranolol; Verapamil | 1982 |
Hemodynamic effects of cadralazine or chlorthalidone in verapamil-treated elderly hypertensives.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Chlorthalidone; Double-Blind Method; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Male; Pyridazines; Verapamil | 1994 |
Vascular complications in hypertension: the VHAS study. Verapamil-Hypertension Atherosclerosis Study.
Topics: Adult; Aged; Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Chlorthalidone; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Verapamil | 1995 |
Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Carbohydrate Metabolism; Chlorthalidone; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Indoles; Male; Middle Aged; Prospective Studies; Verapamil | 1996 |
Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
Topics: Adult; Aged; Antihypertensive Agents; Atenolol; Blood Pressure; Chlorthalidone; Delayed-Action Preparations; Double-Blind Method; Drug Combinations; Drug Tolerance; Female; Humans; Hydrochlorothiazide; Hypertension; Indoles; Lisinopril; Male; Middle Aged; Safety; Verapamil | 1997 |
Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators.
Topics: Adult; Aged; Arteriosclerosis; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Verapamil | 1997 |
The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness.
Topics: Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Arteriosclerosis; Basal Metabolism; Blood Pressure; Carotid Artery, Common; Chlorthalidone; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Prospective Studies; Reference Values; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography; Verapamil | 1998 |
Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Biomarkers; Blood Glucose; Blood Pressure; Chlorthalidone; Diabetes Mellitus, Type 2; Diastole; Diuretics; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Heart Rate; Humans; Hypertension; Indoles; Male; Middle Aged; Patient Compliance; Systole; Treatment Outcome; Vasodilator Agents; Verapamil | 2003 |
9 other study(ies) available for verapamil and chlorthalidone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Effect of verapamil on the pressure response induced by cycloergometry in hypertensive patients].
Topics: Adult; Blood Pressure; Chlorthalidone; Drug Therapy, Combination; Exercise Test; Female; Humans; Hypertension; Male; Middle Aged; Oxygen Consumption; Verapamil | 1979 |
Effect of treatment with chlorthalidone and atenolol on response to dilator agents in the forearm resistance vessels of men with primary hypertension.
Topics: Adult; Aged; Atenolol; Chlorthalidone; Forearm; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Regional Blood Flow; Vascular Resistance; Vasodilator Agents; Verapamil | 1983 |
[Verapamil as a hypotensive agent. Clinical, laboratory, electro- and echocardiographic study].
Topics: Adult; Aged; Chlorthalidone; Echocardiography; Electrocardiography; Female; Humans; Hypertension; Liver; Male; Metoprolol; Middle Aged; Propanolamines; Verapamil | 1981 |